Ignite Creation Date:
2025-12-25 @ 3:26 AM
Ignite Modification Date:
2025-12-26 @ 2:06 AM
Study NCT ID:
NCT03542305
Status:
COMPLETED
Last Update Posted:
2021-02-21
First Post:
2018-05-18
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Lorlatinib Renal Impairment Study
Sponsor:
Pfizer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-08-23
Start Date Type:
ACTUAL
Primary Completion Date:
2020-02-20
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-02-20
Completion Date Type:
ACTUAL
First Submit Date:
2018-05-18
First Submit QC Date:
None
Study First Post Date:
2018-05-31
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2021-02-02
Results First Submit QC Date:
None
Results First Post Date:
2021-02-21
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-02-02
Last Update Post Date:
2021-02-21
Last Update Post Date Type:
ACTUAL